Blume Capital Management, Inc. Novo Nordisk A S Transaction History
Blume Capital Management, Inc.
- $428 Million
- Q4 2024
A detailed history of Blume Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Blume Capital Management, Inc. holds 75 shares of NVO stock, worth $6,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 126
40.48%
Holding current value
$6,174
Previous $15,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,876Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.64 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.28 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.07 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.04 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $186B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...